Supriya Lifescience IPO is to hit the market on December 16 and is to be closed on December 20. Supriya Lifescience IPO to raise around Rs.700 crores via IPO that comprises fresh issue of Rs.200 crores and offer for sale up to Rs.500 croresof Rs.2 each. The retail quota is 10% while QIB is 75% and HNI is 15%.
Supriya
Lifescience is a manufacturer of Active pharmaceuticals ingredients
(APIs). They are consistently one of the largest exporters of
Chlorpheniramine Maleate and Ketamine Hydrochloride from India. The
niche product range includes 39 APIs focused on diverse therapeutic
segments such as antihistamine, analgesic, anesthetic, vitamin,
anti-asthmatic and anti-allergic. They are exporting their products to
78 countries and 0ver 2000 customers and over 280 distributors. The
client's list includes names like Syntec Do Brasil LTDA, American
International Chemical Inc, and AT Planejamento E Desenvolvimento De
Negocios Ltda, Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd, and
Mankind Pharma Ltd. The manufacturing facility is located in
Maharashtra.
Supriya Lifescience IPO Details
| Subscription Dates | 16 – 20 December 2021 |
| Price Band | INR265 – 274 per share |
| Fresh issue | INR200 crore |
| Offer For Sale | INR500 crore |
| Total IPO size | INR700 crore |
| Minimum bid (lot size) | 54 shares |
| Face Value | INR 2 per share |
| Retail Allocation | 10% |
| Listing On | NSE, BSE |
Supriya Lifescience IPO Market Lot
The Supriya Lifescience IPO minimum market lot is 54 shares with Rs.14,796 application amount. The retail investors can apply up-to 13 lots, 702 shares with Rs.192,348 application amount.
Supriya Lifescience IPO Date, Time Table, Allotment & Listing
The Supriya Lifescience IPO date is 16 December 2021 and the IPO close date is 20 December 2021. The allotment date is 23 December 2021 and the IPO may list on 28 December 2021.
Supriya Lifescience Company Financial Report
| Rs. in Crores | |||||
| Income | Expense | PAT |
|||
| 2019 | Rs.286 | Rs.213 | Rs.39.42 | ||
| 2020 | Rs.323 | Rs.213 | Rs.73.37 | ||
| 2021 |
Rs.396 | Rs.218 | Rs.123.8 | ||
Supriya Lifescience IPO GMP(latest)
GMP - Rs. 120
Kostak- Rs.250
Subject to Sauda-Rs.3800
Company Promoters
- Satish Waman Wagh
Supriya Lifescience IPO Registrar
Link Intime India Private Limited
C-101, 247 Park, 1stFloor, L.B.S.Marg,
Vikhroli West Mumbai 400 083
Maharashtra. India
Tel: +91 22 4918 6200
E-mail: supriyalife.ipo@linkintime.co.in
Website: www.linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.:INR000004058
Note: Check Supriya Lifescience IPO allotment status on Linkintime website allotment URL.
Supriya Lifescience IPO Lead Managers
- Axis Capital Limited
- ICICI Securities Limited
Company Address
Supriya Lifescience Limited
207/208, Udyog Bhavan, Sonawala Road,
Goregaon–East, Mumbai – 400063,
Maharashtra, India
Tel: +91-22-40332727
Contact Person: Shweta Shivdhari Singh
Company Secretary and Compliance Officer
Tel: +91-22-40332727
E-mail: cs@supriyalifescience.com
Website: www.supriyalifescience.com
This comment has been removed by the author.
ReplyDelete